Listar CIENCIAS EXPERIMENTALES por autor "Romero, Julián"
Mostrando ítems 1-17 de 17
-
A Glial Endogenous Cannabinoid System Is Upregulated in the Brains of Macaques with Simian Immunodeficiency Virus-Induced Encephalitis Benito, Cristina; Kim, Wong-Ki; Chavarría, Iván; J. Hillard, Cecilia; Mackie, Ken; M. Tolón, Rosa; Williams, Ken; Romero, Julián (The Journal of Neuroscience, 9, 2005)
-
Altered glial expression of the cannabinoid 1 receptor in the subiculum of a mouse model of Alzheimer's disease. Terradillos, Itziar; Bonilla-Del Río, Itziar; Puente, Nagore; Serrano, Maitane; Mimenza, Amaia; Lekunberri, Leire; Anaut-Lusar, Ilazki; Reguero, Leire; Gerrikagoitia, Inmaculada; Ruiz de Martín Esteban, Samuel; Hillard, Cecilia J.; Grande Rodríguez, Mª Teresa; Romero, Julián; Elezgarai, Izaskun; Grandes, Pedro (Glia, 2022)
-
Cannabinoid CB1 and CB2 Receptors and Fatty Acid Amide Hydrolase Are Specific Markers of Plaque Cell Subtypes in Human Multiple Sclerosis Benito, Cristina; Romero Muñoz, Juan Pablo; Tolón, Rosa María; Clemente, Diego; Docagne, Fabián; J. Hillard, Cecilia; Guaza, Carmen; Romero, Julián (The Journal of Neuroscience 9,, 2007-02-28)
-
Cannabinoid CB2 Receptors Modulate Microglia Function and Amyloid Dynamics in a Mouse Model of Alzheimer’s Disease. Ruiz de Martín Esteban, Samuel; Benito Cuesta, Irene; Terradillos, Itziar; Martínez Relimpio, Ana María; Arnanz, M. Andrea; Ruiz-Pérez, Gonzalo; Korn, Claudia; Raposo, Catarina; Sarott, Roman C.; Westphal, Matthias V.; Elezgarai, Izaskun; Carreira, Erick M.; Hillard, Cecilia J.; Grether, Uwe; Grandes, Pedro; Grande Rodríguez, Mª Teresa; Romero, Julián (Frontiers in Pharmacology, 2022)
-
Conditional deletion of CB2 cannabinoid receptors from peripheral sensory neurons eliminates CB2-mediated antinociceptive efficacy in a mouse model of carrageenaninduced inflammatory pain. Hohmann, Andrea G.; Guenther, Kelsey G.; Xu, Zhili; Romero, Julián; Hillard, Cecilia J.; Mackie, Ken (Neuropharmacology, 2023)
-
Development of High-Specificity Fluorescent Probes to Enable Cannabinoid Type 2 Receptor Studies in Living Cells. Sarott, Roman C.; Westphal, Matthias V.; Pfaff, Patrick; Romero, Julián; Ruiz de Martín Esteban, Samuel (Journal of the American Chemical Society, 2020)
-
Effects of Chronic, Low-Dose Cannabinoids, Cannabidiol, Delta-9-Tetrahydrocannabinol and a Combination of Both, on Amyloid Pathology in the 5xFAD Mouse Model of Alzheimer's Disease Arnanz, María Andrea; Ruiz de Martín Esteban, Samuel; Martínez Relimpio, Ana María; Rimmerman, Neta; Tweezer Zaks, Nurit; Grande, María Teresa; Romero, Julián (Cannabis and Cannabinoid Research, 2023)
-
Endocannabinoid levels in peripheral blood mononuclear cells of multiple sclerosis patients treated with dimethyl fumarate. Sánchez‑Sanz, Alicia; Posada Ayala, María; Sabín‑Muñoz, Julia; Fernández‑Miranda, Ismael; ; Álvarez‑Lafuente, Roberto; Royuela, Ana; García‑Hernández, Ruth; Rodríguez‑De la Fuente, Ofir; Romero, Julián; García Merino, Antonio; Sánchez‑López, Antonio José; Aladro Benito, Yolanda (Scientific Reports, 2022)
-
Peripheral sensory neuron CB2 cannabinoid receptors are necessary for both CB2-mediated antinociceptive efficacy and sparing of morphine tolerance in a mouse model of anti-retroviral toxic neuropathy. Carey, Lawrence; Xu, Zhili; Rajic, Gabriela; Makriyannis, Alexandros; Romero, Julián; Hillard, Cecilia; Mackie, Ken; Hohmann, Andrea G. (Pharmacological Research, 2023)
-
Potentiation of amyloid beta phagocytosis and amelioration of synaptic dysfunction upon FAAH deletion in a mouse model of Alzheimer’s disease. Ruiz Pérez, Gonzalo; Ruiz de Martín Esteban, Samuel; Marqués, Sharai; Aparicio, Noelia; Grande Rodríguez, Mª Teresa; Benito Cuesta, Irene; Martínez Relimpio, Ana María; Arnanz, M. Andrea; Tolón, Rosa María; Posada Ayala, María; Cravatt, Benjamin F.; Esteban, José A.; Romero, Julián; Palenzuela Muñoz, Rocío (Journal of Neuroinflammation, 2021)